THE PROBLEM WITH THE TRADITIONAL MODEL
Case review is inconsistent, wasting time and money while frustrating patients.
In this traditional model, patients may continue using a therapy providing no real benefit, costing payors millions in mounting drug and claims costs.
Case review is consistent and results are dependable and communicated clearly.
With InCircle Review, only patients needing therapy are approved, ensuring they receive the right drug at the right dose without significantly adding to the initial treatment timeline.
HOW IT WORKS
Our proprietary algorithm is backed
by disease state experts on staff.
Our proprietary algorithm is backed by disease state experts on staff.
At InCircle Review, we’ve reinvented how specialty drug cases are reviewed and approved from the ground up. We review every case so you don’t have to.
Submit Your Records
Securely submit all examination, test results, and other documentation into the InCircle Review Portal (which can be added to a payor website).
Data is Reviewed
Our proprietary algorithm and disease state experts
verify case data against payor policies and a final
recommendation is created based on the analysis.
Our proprietary algorithm and disease state experts verify case data against payor policies and a final recommendation is created based on the analysis.
Results are Shared
The data leading to the recommendation, along with a summary of findings, is made available, with key stakeholders and care providers alerted as necessary.
You Save Money and
You Save Money and Improve Outcomes
The InCircle Review model helps you save on your drug spend while improving patient outcomes without unnecessary therapy, time, or costs.
Why InCircle Review?
Eliminate Guesswork. Minimize Waste. Lower Costs.
More than 50% of patients are prescribed drugs inappropriately.
InCircle Review was created to improve utilization, minimize misdiagnosis, and enhance clinical outcomes for patients with complex neurological disorders.
Every case we review with our proprietary algorithm-based approach ensures transparent and consistent communication so all stakeholders know exactly why a treatment is being rejected or utilized.
Created by leading neuromuscular physicians Jonathan Katz, M.D., and Todd Levine, M.D., InCircle Review helps payors and MCOs improve care, minimize waste, and decrease drug spend for expensive therapies like Intravenous Immunoglobulin Therapy (IVIg).
NEWS & UPDATES
Discover if InCircle Review can help reduce your drug spend and improve patient outcomes. Schedule a demo today.